Mohammed AbuAlia

Dr. Mohammed AbuAlia

Orthopedic Surgery, Rush University, Chicago, Illinois, USA
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2024 in Lubricants
Verified
Journal Article
Open access
PDF file
MAMohammed AbuAlia
Mohammed AbuAlia
SFSpencer Fullam
Spencer Fullam
Filippo CinottiFilippo Cinotti
Filippo Cinotti
NMNoora Manninen
Noora Manninen
Markus A. A WimmerMarkus A. A Wimmer
Markus A. A Wimmer
While titanium nitride (TiN) coatings are well known for their biocompatibility and excellent mechanical properties, their wear particle and debris release in orthopedic implants remains a matter of active investigation. This study addresses the efficacy of TiN coatings on CoCrMo and Ti6Al4V alloys to enhance wear resistance and reduce ion release from prosthetic implants. Three different coating variants were utilized: one variant deposited using arc evaporation (Arc) followed by post-treatment, and two variants deposited using high-power impulse magnetron sputtering (HiPIMS) with or without post-treatment. The coatings’ performance was assessed through standard wear testing against ultra-high-molecular-weight polyethylene (UHMWPE) in bovine serum lubricant, and in the presence of abrasive PMMA bone cement particles in the lubricant. The results indicated that Arc and HiPIMS with post-treatment significantly reduced wear and eliminated detectable metal ion release, suggesting that these coatings could extend implant longevity and minimize adverse biological responses. Further long-term simulator and in vivo studies are recommended to validate these promising findings.

6 June 2016 in Journal of Chemical Education
Verified
Journal Article
Closed access
MAMohammed AbuAlia
Mohammed AbuAlia
LSLianne Schroeder
Lianne Schroeder
MGMegan Garcia
Megan Garcia
PDPatrick L. Daubenmire
Patrick L. Daubenmire
DWDonald J. Wink
Donald J. Wink
GCGinevra A. Clark
Ginevra A. Clark

9 June 2017 in Journal of Chemical Education
Verified
Journal Article
Closed access
JDJennifer P. Domingo
Jennifer P. Domingo
MAMohammed AbuAlia
Mohammed AbuAlia
DBDiana Barragan
Diana Barragan
LSLianne Schroeder
Lianne Schroeder
DWDonald J. Wink
Donald J. Wink
GCGinevra A. Clark
Ginevra A. Clark

28 October 2026 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Open access
ECErin K. Contino
Erin K. Contino
MAMohammed AbuAlia
Mohammed AbuAlia
BNBrad Nelson
Brad Nelson
LGLaurie R. Goodrich
Laurie R. Goodrich
MBMyra Barrett
Myra Barrett
KSKathryn Seabaugh
Kathryn Seabaugh
Objective: To evaluate the symptom- and disease-modifying effects of injectable 2.5% polyacrylamide gel (iPAAG) in an experimental model of equine osteoarthritis (OA). Methods: 16 horses underwent osteochondral fragment creation (day 0) in 1 randomly-selected middle carpal joint (MCJ). On day 14, the MCJ was injected with 2 mL of phosphate-buffered saline (n = 8) or 2.5% iPAAG (8); high-speed treadmill exercise commenced on day 16 to induce OA. Clinical parameters (lameness, joint effusion, range of motion, flexion response) and synovial fluid were collected weekly and biweekly, respectively. Radiographs were obtained before surgery, at day 14, and at day 70. Postmortem evaluation (day 70) included gross, arthroscopic, and histopathologic evaluation of the MCJs and measurement of joint capsule stiffness. Results: There were no significant differences in clinical parameters or endpoint arthroscopic, macroscopic, or synovial membrane histopathology scores between groups. In 2.5% iPAAG–treated limbs, the third carpal bone had significantly lower (better) total articular cartilage histology scores (6.38 ± 4.10 vs 11.25 ± 4.20) and proteoglycan staining scores of the intermediate articular cartilage layer (0.38 ± 0.74 vs 1.88 ± 1.25) compared to saline-treated OA joints. Saline-treated OA joints had significantly increased joint capsule stiffness versus contralateral sham-operated MCJs (1,824 ± 1,105 vs 1,002 ± 495 Pa), whereas 2.5% iPAAG–treated joints did not (1,099 ± 647 vs 1,184 ± 504 Pa). Conclusions: Treatment with 2.5% iPAAG showed some ability to mitigate the negative effects of OA on articular cartilage. Treatment also resulted in retention of normal joint capsule elasticity during the progression of OA. Clinical Relevance: Treatment with 2.5% iPAAG may result in retention of normal joint capsule elasticity in horses with naturally occurring OA.